Plasma post-heparin lipase activities in the HERITAGE Family Study: The reproducibility, gender differences, and associations with lipoprotein levels

Clinical Biochemistry

Volumn 32, Issue 3, 1999, Pages 157-165

  Després, Jean Pierre ^a,b   Gagnon, Jacques ^a   Bergeron, Jean ^b   Couillard, Charles ^b   Leon, Arthur S ^d   Rao, D C ^c   Skinner, James S ^e   Wilmore, Jack H ^f   Bouchard, Claude ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b Université Laval   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e INDIANA UNIVERSITY   (United States)

^f TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Apolipoprotein; Cholesterol; HDL cholesterol; Hepatic triglyceride lipase; LDL cholesterol; Lipoprotein lipase

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032975334     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00106-4     Document Type: Article

References (29)

1. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High density lipoprotein cholesterol and cardiovascular disease Four prospective American studies . Circulation. 79:1989;8-15.
2. The Lipid Research Clinics Coronary Primary Prevention Trial Results The relationship of reduction in incidence of coronary heart disease to cholesterol lowering . JAMA. 251:1984;365-374.
3. Castelli W.P., Garrison R.J., Wilson P.W.F., et al. Incidence of coronary heart disease and lipoprotein cholesterol levels The Framingham Study . JAMA. 256:1986;2835-2838.
4. Design and baseline results of the Scandinavian Survival Study of patients with stable angina and/or previous myocardial infarction. Am J Cardiol. 71:1993;393-400.
5. Manninen V., Elo M.O., Frick K., et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 260:1988;641-651.
6. Tikkanen M.J., Nikkilä E.A. Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J. 113:1987;562-567.
7. Taskinen M.R., Nikkilä E.A., Huttunen J.K., Hilden H. A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle. Clin Chim Acta. 104:1980;107-117.
8. Després J.P., Ferland M., Moorjani S., et al. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 9:1989;485-492.
9. Myers G.L., Cooper G.R., Sampson E.J. Traditional lipoprotein profile Clinical utility, performance requirements and standardization . Atherosclerosis. 108:1994;S157-S169.
10. Chambless L.E., McMahon R.P., Brown S.A., et al. Short-term intraindividual variability in lipoprotein measurements The Atherosclerosis Risk in Communities (ARIC) Study . Am J Epidemiol. 136:1992;1069-1081.
11. Christenson R.H., Roeback J.R., Watson T.E., Hla K.M. Improving the reliability of total and high-density lipoprotein cholesterol measurements - Four testing strategies compared in high-risk population. Arch Pathol Lab Med. 115:1991;1212-1216.
12. McManus B.M., Toth A.B., Engel J.A., et al. Progress in lipid reporting practices and reliability of blood cholesterol measurement in clinical laboratories in Nebraska - Efforts to align results with the Centers for Disease Control, and feasibility of meeting National Cholesterol Education Program guidelines. JAMA. 262:1989;83-88.
13. Naito H.K. Reliability of lipid, lipoprotein, and apolipoprotein measurements. Clin Chem. 34:1988;B84-B94.
14. Bouchard C., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., Gagnon J. The HERITAGE Family Study Aims, design, and measurement protocol . Med Sci Sports Exerc. 27:1995;721-729.
15. Gagnon J., Province M.A., Bouchard C., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H. The HERITAGE Family Exercise Study Quality Assurance and Quality Control . Ann Epidemiol. 6:1996;520-529.
16. Moorjani S., Dupont A., Labrie F., et al. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism. 36:1987;244-250.
17. Burstein M., Samaille J. Sur un dosage rapide du cholestérol lié aux β-lipoprotéines du sérum. Clin Chim Acta. 5:1960;609-610.
18. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 15:1966;45-52.
19. Avogaro P., Bittolo Bon G., Cazzolato G., Quinci G.B. Are apolipoprotein better discriminators than lipids for atherosclerosis? Lancet. 1:1979;901-903.
20. Gidez LI, Miller GJ, Burstein M, Slage S, Eder HH. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lip Res 1982; 23: 1206-23.
21. Nilsson-Ehle P., Ekman R. Specific assays for lipoprotein lipase and hepatic lipase activities of post-heparin plasma. Peeters H. Protides of biological fluids. 1978;243-246 Pergamon Press, Oxford.
22. St-Amand J., Moorjani S., Lupien P.J., Prud'homme D., Després J.P. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotein E polymorphism. Metabolism. 45:1996;261-267.
23. Shrout P.E., Fleiss J.L. Intraclass correlations Uses in assessing rater reliability . Psychol Bull. 86:(2):1979;420-428.
24. Bookstein L., Gidding S.S., Donovan M., Smith F.A. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines. Arch Intern Med. 150:1990;1653-1657.
25. Laboratory Standardization Panel. National Cholesterol Education Program. National Heart, Lung and Blood Institute. Recommendations for improving cholesterol measurement. Bethesda, MD: National Cholesterol Education Program; February 1990: 1-81, NIH publication 90-2964.
26. Cooper G.R., Myers G.L., Smith J., Schlant R.C. Blood lipid measurements. Variations and practical utility. JAMA. 267:1992;1652-1660.
27. St-Amand J., Després J.P., Lemieux S., et al. Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women? Metabolism. 44:1995;491-498.
28. Blades B., Vega G.L., Grundy S.M. Activities of lipoprotein lipase and hepatic lipase in post-heparin plasma of patients with low concentrations of HDL-cholesterol. Arterioscler Thromb. 13:1993;1227-1235.
29. Kissebah A.H., Krakower G.R. Regional adiposity and morbidity. Physiol Rev. 74:1994;761-811.